Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment
Clinical trial NCT00126867 · TERMINATED
Trial details
- NCT number
- NCT00126867
- Sponsor
- AHS Cancer Control Alberta
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2005-05-01
- Primary completion
- 2019-04-11
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.